'Why do children with cerebral palsy discontinue therapy with botulinum toxin A?'

Dev Med Child Neurol. 2006 Apr;48(4):319-20. doi: 10.1017/S0012162206000697.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Antibodies / immunology
  • Botulinum Toxins, Type A / immunology
  • Botulinum Toxins, Type A / therapeutic use*
  • Cerebral Palsy / drug therapy*
  • Child
  • Humans
  • Neuromuscular Agents / therapeutic use*
  • Retrospective Studies
  • Withholding Treatment

Substances

  • Antibodies
  • Neuromuscular Agents
  • Botulinum Toxins, Type A